genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Bioprocessing
Lonza Plans New Fill & Finish Facility in Stein, Switzerland
Bioprocessing
Harnessing Bacteria to Make Jet Fuel: Not Just An “Explosive Idea?”
Drug Discovery
Potential Therapeutic Treatment for Androgenetic Alopecia
Dengue
Mosquitoes Find Humans Infected with Zika or Dengue Viruses More Attractive
Infectious Diseases
Enteric Viruses Shown Capable of Spreading via Saliva
Insights
All
Trends for 2020
Trends for 2021
Insights
Single-Cell Functional Proteome Profiling Uncovers Novel Targets for Alzheimer’s Disease
Artificial Intelligence
AI Can Make a Difference on the Factory Floor If Biopharma…
Bioprocessing
Separation Technique Adjusted for mRNA Vaccine Boom
Antibodies
Combatting Therapeutic-Protein Aggregation
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Therapeutics
Enzyme Replacement Therapy
Enzyme Replacement Therapy
Anti-Ulcerants
Antibacterials
Antibiotics
Anticoagulants
Antidiabetics
Antifungals
Antivirals
Autoimmune Disease Drugs
Biologics
Biosimilars
Cardiovascular Drugs
Cellular Therapeutics
Combination Therapies
Dermatologic Drugs
Enzyme Replacement Therapy
Generics
Hormone Replacement Therapy
Immuno-oncology
Immunotherapies
Lipid Regulators
Mental Health Drugs
Oncologics
Orphan Drugs
Pain
Protein Therapeutics
Psychoactive Drugs
Radiopharmaceuticals
Respiratory Drugs
Traditional Chinese Medications
Vaccines
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Enzyme Replacement Therapy
Rubius Therapeutics Closes $120M Financing, Plans Trials Next Year
Enzyme Replacement Therapy
Alexion to Eliminate 7% of Workforce
Enzyme Replacement Therapy
Amicus Cuts Jobs, Overhauls GSK Collab, and Acquires Callidus
Enzyme Replacement Therapy
Lonza to Manufacture Heart Failure Enzyme Replacement Therapy
Enzyme Replacement Therapy
Genzyme Gets FDA, EMA Approvals for Production Plant in Waterford, Ireland
Enzyme Replacement Therapy
Protalix, Pfizer Report FDA Approval of Plant-Derived Gaucher Disease ERT Elelyso
Enzyme Replacement Therapy
EMA Green-Lights Shire’s Manufacturing Site in Lexington, MA, for Gaucher Therapy
Enzyme Replacement Therapy
Alexion Pays $610M to Buy Enobia for Hypophosphatasia ERT Candidate
Enzyme Replacement Therapy
Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase...
Enzyme Replacement Therapy
Enobia Raises $40M to Further Develop Phase II-Stage ERT for Hypophosphatasia
Enzyme Replacement Therapy
Synageva Merges with Trimeris in All-Stock Deal
Enzyme Replacement Therapy
Halozyme and Intrexon to Develop Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy
Enzyme Replacement Therapy
Synageva Raises $25M Through Private Placement with Existing Investors
Enzyme Replacement Therapy
Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy
Enzyme Replacement Therapy
GSK Pays Amicus $30M Up Front for Phase III Fabry Disease...
1
2
Page 1 of 2
Scroll Up